Blue Point Capital Partners has recapitalized OrthoLite. Company management also participated in the transaction. Financial terms weren’t announced. Amherst, Mass.-based OrthoLite supplies comfort insoles and related shoe components to branded footwear company. BB&T Capital Markets provided financial advice to OrthoLite.
On April 17, 2014, Blue Point Capital Partners and company management announced the recapitalization of OrthoLite, the leading supplier of comfort insoles and related shoe components to over 130 of the world’s most prominent branded footwear companies. Terms of the agreement were not disclosed. BB&T Capital Markets served as the exclusive financial advisor to OrthoLite in the transaction.
The recapitalization of OrthoLite represents BB&T Capital Markets’ fifth branded consumer products transaction in the last 12 months.
“Glenn Barrett (Chairman and CEO), Pam Gelsomini (President), John Barrett (Asia General Manager) and their global leadership team have done an exceptional job in developing a world-class brand through ongoing product innovation and unparalleled customer service,” said Rex Green, Managing Director and Head of BB&T Capital Markets’ Retail and Consumer group. “OrthoLite’s track record of growth is a testament to the company’s extraordinary value proposition to many of the world’s leading footwear brands.”
“We are very proud to have worked with the OrthoLite team on this transaction,” added Joe Sparacino, a Vice President in BB&T Capital Markets’ Boston office. “We are excited to see the company begin its next phase of growth in partnership with Blue Point.”